Trial Profile
Clinical Trials Insight: 700032660
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 26 Apr 2024
Price :
$35
*
At a glance
- Drugs Insulin lispro (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Diasome Pharmaceuticals
- 17 Apr 2008 New trial record.
- 16 Apr 2008 Diasome expects to initiate this study in mid-2008.